Intravitreal Bevacizumab in Agioid Streaks

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the safety and efficacy of intravitreal bevacizumab in patients with choroidal neovascularization associated with angioid streaks.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Second University of Naples; University of Campania "Luigi Vanvitelli"
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• presence of an active CNV

• visual loss

• increased retinal thickness

Exclusion Criteria:

• no actively leaking CNV by FAG

• normal retinal thickness

• satisfactory visual acuity